Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

A woman developed male traits from accidental contact with her husband's testosterone gel.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Exercising women should be screened for anemia due to its prevalence and impact on performance.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Obesity is strongly linked to the severity of hirsutism in women.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Removing both ovaries treated the woman's excess male hormone symptoms.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Low iron levels may be linked to hair loss in non-menopausal women.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.